Want to join the conversation?
$MRK's research and development expenses for 3Q15 fell 10% from last year. The decline reflects reduction in expenses resulting from decrease in estimated fair value of liabilities for contingent consideration, favorable effects of FX, lower restructuring costs and prior year divestiture of MCC, partially offset by higher Cubist acquisition costs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?